AGP Executive Report
Last update: 5 hours agoOvarian Cancer Breakthrough (NHS): NHS England has approved mirvetuximab soravtansine (Elahere) for hundreds of women with platinum-resistant ovarian cancer carrying FRα, following trial results showing longer survival and delayed progression. NHS Data Sovereignty Row: MPs on the Commons science committee want ministers to use a 2027 break clause to end reliance on Palantir’s NHS Federated Data Platform, warning of “vendor lock-in” and foreign-actor risk. Welsh NHS Plans (Workforce & Access): Health unions gave partial support to Plaid Cymru’s NHS priorities in Wales, including new surgical/diagnostic hubs and GP recruitment, but doctors’ leaders say corridor care must end. Ebola Monitoring Update: UK health officials say surveillance of BA253 passengers has concluded after negative Ebola tests, while broader readiness work continues. Eye-Care Waiting Times: New figures suggest almost all English NHS trusts miss eye-care targets, with many patients waiting over 18 weeks and cost concerns driving people to delay appointments. Antisemitism Crackdown (NHS): A review recommends new uniform rules and improved reporting after findings that Jewish staff and patients feel they must “suffer in silence.” Everyday Health & Wellness: Sainsbury’s will phase out brown eggs for white-shell eggs, citing lower carbon emissions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
